Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 6/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | PDE2A | O00408 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | KDM1A | O60341 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.35 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.35 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22795543 | 0.92 | PDE2A (0.43) | ACHETDP1PDE2AALDH1A1CA1 | |
| SCHEMBL17651164 | 0.85 | NFE2L2 (0.58) | PDE2ACA1MAPTLMNANFE2L2 | |
| SCHEMBL17431633 | 0.85 | NFE2L2 (0.58) | PDE2ACA1MAPTLMNANFE2L2 | |
| SCHEMBL1970199 | 0.83 | PDE2A (0.52) | PDE2AKDM1A | |
| SCHEMBL12353980 | 0.77 | ACHE (0.44) | ACHETDP1PDE2AALDH1A1CA1 | |
| SCHEMBL26496096 | 0.77 | ACHE (0.44) | ACHETDP1ALDH1A1CA1CA2 | |
| P-Xylene SCHEMBL3847044 | 0.75 | — | — | |
| SCHEMBL19665045 | 0.75 | RXRA (0.45) | ACHEPDE2AALDH1A1KDM1ATSHR | |
| SCHEMBL4621106 | 0.75 | CYP1A2 (0.59) | TDP1PDE2AALDH1A1CA9MAPT | |
| SCHEMBL17431626 | 0.73 | PDE2A (0.46) | TDP1PDE2AALDH1A1KDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 179 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110301382-A1 | Processes for Preparing 1,3-Dinitro-5-(Pentafluorosulfanyl)Benzene and its Intermediates | UBE INDUSTRIES, LTD. (JP) | 2011-12-08 | — | — | US | claimed |
| EP-4595143-A1 | TERNARY SOLVENT ELECTROLYTES FOR HIGH VOLTAGE AND HIGH RATE LITHIUM BATTERIES | Sepion Technologies, Inc. (US) | 2025-08-06 | — | — | EP | disclosed |
| CN-120202571-A | Ternary solvent electrolyte for high voltage and high rate lithium battery | 赛鹏科技有限公司 | 2025-06-24 | — | — | CN | disclosed |
| US-12172980-B2 | Compounds as neuronal histamine receptor-3 antagonists and uses thereof | XWPharma Ltd. (KY) | 2024-12-24 | — | — | US | disclosed |
| WO-2024073410-A1 | TERNARY SOLVENT ELECTROLYTES FOR HIGH VOLTAGE AND HIGH RATE LITHIUM BATTERIES | SEPION TECHNOLOGIES, INC. (US) | 2024-04-04 | — | — | WO | disclosed |
| WO-2024017977-A1 | IMIDAZOPYRIDINE COMPOUNDS, PREPARATION THEREOF AND THERAPEUTIC USES THEREOF | SANOFI (FR) | 2024-01-25 | — | — | WO | disclosed |
| WO-2024003259-A1 | TEAD INHIBITORS | BAYER AKTIENGESELLSCHAFT (DE) | 2024-01-04 | — | — | WO | disclosed |
| US-11820767-B2 | Benzyl amine-containing heterocyclic compounds and compositions useful against mycobacterial infection | UNIVERSITY OF NOTRE DAME DU LAC (US) | 2023-11-21 | — | — | US | disclosed |
| CN-116940551-A | Method for producing aryl compound containing pentafluorothio group | ＡＧＣ株式会社 | 2023-10-24 | — | — | CN | disclosed |
| EP-4260704-A1 | ANTIMICROBIAL COMPOSITIONS COMPRISING A PHENYL UREA COMPOUND AND A CIS-UNSATURATED FATTY ACID WITH 16 TO 22 CARBON ATOMS | National Taiwan University (TW) | 2023-10-18 | — | — | EP | disclosed |
| US-7608604-B2 | Antiparasitic agents | PFIZER LIMITED (GB) | 2009-10-27 | — | — | US | disclosed |
| US-20090264525-A1 | FLUOROSURFACTANTS | MERCK PATENT GMBH (DE) | 2009-10-22 | — | — | US | disclosed |
| US-7592491-B2 | Process for producing arylsulfur pentafluorides | IM&T RESEARCH, INC. (US) | 2009-09-22 | — | — | US | disclosed |
| US-7592491-B2 | Process for producing arylsulfur pentafluorides | IM&T RESEARCH, INC. (US) | 2009-09-22 | — | — | US | disclosed |
| US-20090203667-A1 | PENTADIENAMIDE DERIVATIVES | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2009-08-13 | — | — | US | disclosed |
| US-20090197201-A1 | FLUOROSURFACTANTS | MERCK PATENT GESELLSCHAFT (DE) | 2009-08-06 | — | — | US | disclosed |
| WO-2008118787-A1 | PROCESS FOR PRODUCING ARYLSULFUR PENTAFLUORIDES | IM & T RESEARCH, INC. (US) | 2008-10-02 | — | — | WO | disclosed |
| US-20080234520-A1 | PROCESS FOR PRODUCING ARYLSULFUR PENTAFLUORIDES | IM&T RESEARCH, INC. (US) | 2008-09-25 | — | — | US | disclosed |
| US-20080234520-A1 | PROCESS FOR PRODUCING ARYLSULFUR PENTAFLUORIDES | IM&T RESEARCH, INC. (US) | 2008-09-25 | — | — | US | disclosed |
| US-20080194694-A1 | nematocides such as N-{1-cyano-2-[5-cyano-2-(trifluoromethyl)phenoxy]-1-methylethyl}-4-pentafluorothiobenzamide, tautomers or prodrugs, carriers and optionally a second therapeutic agent, used for treating parasitic infestations | PFIZER LIMITED (UK) | 2008-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11820767-B2 | Benzyl amine-containing heterocyclic compounds and compositions useful against mycobacterial infection | BET1, BRD4, BRD3 | ACHE 3100/4885TDP1 3498/4885PDE2A 2367/4885 |
| US-20080194694-A1 | nematocides such as N-{1-cyano-2-[5-cyano-2-(trifluoromethyl)phenoxy]-1-methylethyl}-4-pentafluorothiobenzamide, tautomers or prodrugs, carriers and optionally a second therapeutic agent, used for treating parasitic infestations | HRH4, HRH3, HRH2 | ACHE 441/4885TDP1 2006/4885PDE2A 3598/4885 |
| US-12172980-B2 | Compounds as neuronal histamine receptor-3 antagonists and uses thereof | HRH3, HRH4, HRH2 | ACHE 351/4885TDP1 4538/4885PDE2A 1600/4885 |
| US-20080234520-A1 | PROCESS FOR PRODUCING ARYLSULFUR PENTAFLUORIDES | PFAS, MPST, ARSA | ACHE 3969/4885TDP1 4179/4885PDE2A 4546/4885 |
| US-20090203667-A1 | PENTADIENAMIDE DERIVATIVES | PRMT1, REN, NGLY1 | ACHE 1750/4885TDP1 2689/4885PDE2A 1303/4885 |
| US-20090264525-A1 | FLUOROSURFACTANTS | FASN, FFAR3, SGMS2 | ACHE 4537/4885TDP1 4827/4885PDE2A 3945/4885 |
| US-20110301382-A1 | Processes for Preparing 1,3-Dinitro-5-(Pentafluorosulfanyl)Benzene and its Intermediates | DPYD, FDPS, BLVRB | ACHE 3143/4885TDP1 1727/4885PDE2A 4133/4885 |
| US-20090197201-A1 | FLUOROSURFACTANTS | CBR3, SCO2, FPR3 | ACHE 3633/4885TDP1 4231/4885PDE2A 3630/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.